Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.27
-0.35 (-4.59%)
At close: Feb 5, 2026, 4:00 PM EST
7.19
-0.08 (-1.10%)
After-hours: Feb 5, 2026, 6:51 PM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $415.33 million as of February 5, 2026. Its market cap has increased by 188.04% in one year.
Market Cap
415.33M
Enterprise Value
249.22M
1-Year Change
188.04%
Ranking
Category
Stock Price
$7.27
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $415.33M, a decrease of -53.75%. That is a compound annual growth rate of -32.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 435.33M | -18.94% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| vTv Therapeutics | 451.81M |
| Vanda Pharmaceuticals | 449.13M |
| Eupraxia Pharmaceuticals | 444.78M |
| Niagen Bioscience | 443.29M |
| Absci | 437.58M |
| Tectonic Therapeutic | 434.59M |
| PureTech Health | 434.32M |
| Assembly Biosciences | 427.85M |